Long-term outcome of recombinant INF-alpha treatment of chronic hepatitis C in kidney transplant recipients.
Yasumura
T
T
Second Department of Surgery, Kyoto Prefectural University of Medicine, Japan.
Nakajima
H
H
Hamashima
T
T
Nakai
I
I
Yoshimura
N
N
Ohmori
Y
Y
Oka
T
T
D000328:Adult; D000410:Alanine Transaminase / Q000097:blood; D005500:Follow-Up Studies; D005838:Genotype; D016174:Hepacivirus / Q000235:genetics / Q000302:isolation & purification; D006526:Hepatitis C / Q000175:diagnosis / Q000628:therapy*; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use*; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D016133:Polymerase Chain Reaction; D011183:Postoperative Complications; D012367:RNA, Viral / Q000097:blood; D011994:Recombinant Proteins; D013997:Time Factors; D014184:Transplantation, Homologous
D007370:Interferon Type I; D012367:RNA, Viral; D011994:Recombinant Proteins; D000410:Alanine Transaminase